Hypertension, Vol 22, 780-788, Copyright © 1993 by American Heart Association
HJ Nelissen-Vrancken, HA Boudier, MJ Daemen and JF Smits
In the present experiments the effect of long-term peripheral ischemia on
the capillary of two hind limb skeletal muscles was investigated in
spontaneously hypertensive rats. Furthermore, the effect of
antihypertensive therapy on changes in capillarity and on the previously
observed hyperreactivity of the ischemic vascular bed to vasoconstrictors
was investigated in perfused hind limbs of rats after long-term treatment
with the angiotensin I converting enzyme inhibitors captopril (0.5 mg/kg.h)
or zabiciprilate (0.025 mg/kg.h), the angiotensin II type 1 receptor
antagonist losartan (0.625 mg/kg.h), or the calcium antagonist felodipine
(0.042 or 0.42 mg/kg.h). Skeletal muscle ischemia in the left hind limb was
induced by partial ligation of the left common iliac artery. Long-term (4
weeks) ischemia increased significantly the capillary-to-fiber ratio in the
soleus muscle, composed predominantly of type I fibers in spontaneously
hypertensive rats, of the ischemic hind limb, whereas capillarity in the
contralateral muscle was not affected. Furthermore, capillarity in the
gastrocnemius muscle (type II muscle fiber part) of both the ischemic and
contralateral hind limb did not change. Long-term treatment with the
angiotensin I converting enzyme inhibitors during ischemia abolished the
increase in the capillary-to-fiber ratio in the soleus muscle, whereas a
comparable antihypertensive dose of felodipine had no effect. Greater blood
pressure reductions by both losartan and felodipine prevented increases in
capillarization in skeletal muscle ischemia. With respect to vascular
hyperreactivity during ischemia, only treatment with losartan normalized
reactivity of the ischemic vascular bed to vasoconstrictors.(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
Antihypertensive therapy and adaptive mechanisms in peripheral ischemia
Department of Pharmacology, University of Limburg, The Netherlands.
This article has been cited by other articles:
![]() |
A. T Hirsch and D. Duprez The potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease Vascular Medicine, November 1, 2003; 8(4): 273 - 278. [Abstract] [PDF] |
||||
![]() |
A. Fournier, A. Pruna, N. E. Esper, R. Makdassi, R. Oprisiu, P.-F. Westeel, H. Mazouz, and J.-M. Achard Captopril prevention project--what shall we do about captopril and the risk of stroke? Nephrol. Dial. Transplant., January 1, 2000; 15(1): 2 - 5. [Full Text] [PDF] |
||||
![]() |
H.J.M. G. Nelissen-Vrancken, M. C. Kuizinga, M. J.A.P. Daemen, and J. F.M. Smits Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts Cardiovasc Res, October 1, 1998; 40(1): 156 - 164. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |